Malignant mesothelioma with CD30-positivity. A case report and review of the literature.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 10888787.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The activation marker CD3O is useful in the diagnosis of Hodgkin and non-Hodgkin lymphomas. It has also been described in nonhematopoietic tumors, including pancreatic carcinomas, salivary gland tumors, and embryonal carcinomas. We report a case of malignant mesothelioma with intense CD30 positivity. This finding has not previously been described and is important in broadening the differential diagnosis of a CD30(+) cohesive large cell malignancy.
Medical subject headings
- Ki-1 Antigen
- Mesothelioma
- Pleural Neoplasms